Back to search

Studies on the Removal of Abnormal Prion Protein by Processes Used in the Manufacture of Human Plasma Products

Data up to Jan 2025

Published2000
Citations108
References21

Total Citations Per Year

Abstract

References (21)

A new variant of Creutzfeldt-Jakob disease in the UK

1996 • 2,690 citations

Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent

1997 • 1,951 citations

Preparation and Properties of Serum and Plasma Proteins. IV. A System for the Separation into Fractions of the Protein and Lipoprotein Components of Biological Tissues and Fluids1a,b,c,d

1946 • 1,815 citations

Curcumin has potent anti‐amyloidogenic effects for Alzheimer's β‐amyloid fibrils in vitro

2004 • 1,209 citations

Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples

1999 • 710 citations

Variant Creutzfeldt-Jakob disease

1999 • 514 citations

Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy

1997 • 431 citations

The Separation of the Antibodies, Isoagglutinins, Prothrombin, Plasminogen and β1-Lipoprotein into Subfractions of Human Plasma

1949 • 412 citations

"Friendly fire" in medicine: hormones, homografts, and Creutzfeldt-Jakob disease

1992 • 354 citations

Large Scale Production of Human Plasma Fractions

1962 • 326 citations

Characteristics of a Short Incubation Model of Scrapie in the Golden Hamster

1977 • 310 citations

The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy

1998 • 307 citations

Creutzfeldt-Jakob disease and blood transfusion

1993 • 152 citations

Properties of a Highly Punified Human Plasma Factor IX:c Therapeutic Concentrate Prepared by Conventional Chromatography

1989 • 71 citations

A Highly Purified Factor VIII:c Concentrate Prepared from Cryoprecipitate by Ion‐Exchange Chromatography

1991 • 68 citations

Assessment of the potential of plasma fractionation processes to remove causative agents of transmissible spongiform encephalopathy

1999 • 58 citations

A Therapeutic Concentrate of Coagulation Factors II, IX and X from Citrated, Factor VIII‐Depleted Plasma

1973 • 44 citations

An experimental examination of the scrapie agent in cell membrane mixtures

1971 • 38 citations

Reduction of the Infectivity of Scrapie Agent as a Model for BSE in the Manufacturing Process of Trasylol®

1996 • 37 citations

Control of Large‐Scale Plasma Thawing for Recovery of Cryoprecipitate Factor VIII1

1982 • 33 citations

A Bovine Spongiform Encephalopathy Validation Study for Aprotinin and Bovine Serum Albumin.

1998 • 14 citations

Cited By (0)

Loading...